About Hemab
Hemab is a global, clinical stage biotechnology company focused on re-imagining blood clotting therapies. Based in Cambridge, MA and Copenhagen, Denmark, Hemab is pioneering the first targeted preventative treatments and functional cures for underserved bleeding and thrombotic disorders.
While patients with common bleeding and thrombotic disorders have had access to preventative treatments for more than a half-century, no such measures exist for many patients in need. For these hundreds of thousands of women, men and children, life is paralyzingly unpredictable. A bleeding or thrombotic event can strike any moment, from a simple menstrual period to a routine dental procedure, and cause symptoms so severe that by the time they reach a hospital, it may be too late. It is time to ensure that every clotting disorder patient has the security and peace of mind they deserve.
Hemab’s strategic guidance, Hemab 1-2-5TM, targets the development of 5 assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood-clotting disorders like Glanzmann Thrombasthenia, Factor VII Deficiency, Von Willebrand Disease, and others.
Our program:
The HMB-002 program is advancing a novel antibody to deliver a unique and convenient subcutaneous treatment for patients with Von Willebrand Disease; the most prevalent bleeding disorder in the world. This program is in advanced pre-clinical stage, and the new program leader will see this program through initial regulatory guidance/approval and into the clinic, through Phase I/II studies conducted in a global setting towards pivotal trials.
Program Leader role summary:
At Hemab, all programs entering the IND/CTA enabling phase are managed by a Core Team.
The Program Leader leads this multi-disciplinary program team in an international setting, comprised of functional representatives from research, non-clinical development, clinical development, regulatory, CMC, medical affairs, and commercial to ensure success of the franchise.
The Program Leader serves as a strategic thought partner to the Management Team and is responsible for operationalizing and executing the program strategy.
The Program Leader will ensure that all sub-teams are aware of their overarching objectives, deliverables, and timelines and will drive the program forward according to agreed timelines.
The Program Leader will be responsible for providing a combination of drug development and program oversight to the Core Team and other relevant sub-teams, to maximize the potential of the Hemab assets by ensuring smooth day-to-day operations, enabling timely communications across the teams, and supporting strategic decision-making.
The Program Leader will also coordinate activities associated with global regulatory submissions and launches, as well as life-cycle management planning.
The Program Leader will also be responsible for accurately updating program management reports, timelines and dashboards and drive the identification/implementation of best practices within Hemab.
In this capacity, the Program Leader will call upon direct prior experience to implement proven drug development, commercial, and portfolio best practices and adapt them to the Hemab Operating Model.
Responsibilities:
Experience and Qualifications
Location: Cambridge MA US or Copenhagen